{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-030102","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2025-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.536281+00:00","generated_at":"2026-05-23T18:36:51.860817+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"60 Degrees Pharma enters 12-month option for castanospermine license with Florida State","bullets":["Entered exclusive 12-month option to negotiate a royalty-bearing license for castanospermine purification technology.","Company holds 8.8 kg of Australian Chestnut extract inventory for potential botanical product commercialization.","Castanospermine is a bioactive alkaloid; company already owns IP on synthetic derivative celgosivir for viral diseases.","Company states the option agreement is not material to its business or operations.","Intends to explore non-prescription botanical extracts under changing U.S. regulatory framework."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-030102","json":"https://secwatch.observer/filing/0001213900-25-030102.json","markdown":"https://secwatch.observer/filing/0001213900-25-030102.md","text":"https://secwatch.observer/filing/0001213900-25-030102.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025030102/0001213900-25-030102-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025030102/ea0237280-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:36:51.860817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}